Faron Pharmaceuticals Oy (FARN.L) Stock Price
£210 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
2 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Faron Pharmaceuticals Oy, AI stock picks, stock alerts and much more.
FARN.L AI Stock Analysis
AI stock analysis for FARN.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Faron Pharmaceuticals Oy (FARN.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Faron Pharmaceuticals Oy (FARN.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Faron Pharmaceuticals Oy (FARN.L), currently trading at £210, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About FARN.L
-
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company.
-
Symbol
FARN.L
-
Market
LSE
-
Industry
Biotechnology
-
Market Cap
234.4M
Similar Stocks
 |
Codexis 0I0X.L |
$2.11 0.4% |
3 |
 |
Oxford Nanopore Technologies plc ONT.L |
£117.9 0.3% |
6 |
 |
Sareum Holdings SAR.L |
£17.5 5.4% |
2 |
 |
Viridian Therapeutics 0K1R.L |
$12.91 0.7% |
5 |
 |
Avacta Group Plc AVCT.L |
£35 5.4% |
3 |
News
FARN.L Alternative Data
Web Traffic
Faron Pharmaceuticals Oy receives an estimated 2826 monthly visitors to faron.com.
-
Web Traffic
2826
-
Change from Previous Month
30.4%
-
3 Month Change
66.2%
-
YoY Change
66.2%
News Mentions
Faron Pharmaceuticals Oy was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Faron Pharmaceuticals Oy has 462 Twitter Followers on its main Twitter (also known as X) account, which is up by 3.8% over the last month.
-
Twitter Followers
462
-
Daily Change
0.2%
-
1 Month Change
3.8%
-
3 Month Change
5%
Youtube Subscribers
Faron Pharmaceuticals Oy has 82 subscribers on its main Youtube channel.
-
Youtube Subscribers
82
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
3.8%
Job Postings
Faron Pharmaceuticals Oy has an estimated 0 open job postings, which is down -100% over the last month.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
100%
Reddit Mentions
Faron Pharmaceuticals Oy has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
LinkedIn Employees
According to LinkedIn, Faron Pharmaceuticals Oy has 44 employees.
-
LinkedIn Employees
44
-
Daily Change
4.8%
-
1 Month Change
0%
-
3 Month Change
4.8%
FARN.L Financials
FARN.L Key Metrics
-
Total Revenue
€0
-
Net Income
-€7.2K
-
Earnings per Share
-€0.1
-
Free cash flow
-€4.3K
-
EBITDA
-€5.6K
-
EBITDA Ratio
0
-
Total Assets
€12.5M
FARN.L 2-year Revenue & Income
FARN.L 2-year Free Cash Flow
FARN.L Technicals
FARN.L SMA
FARN.L RSI
FAQ
What's the current price of Faron Pharmaceuticals Oy (FARN.L) Stock?
The price of an Faron Pharmaceuticals Oy (FARN.L) share is £210.
What's the market cap of Faron Pharmaceuticals Oy?
The current market cap of Faron Pharmaceuticals Oy is 234.4M.
Should I buy or sell FARN.L?
Faron Pharmaceuticals Oy shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Faron Pharmaceuticals Oy is better viewed as a hold or accumulate position while waiting for further developments.
Is Faron Pharmaceuticals Oy a good investment?
The current analysis of Faron Pharmaceuticals Oy's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Faron Pharmaceuticals Oy's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Faron Pharmaceuticals Oy (FARN.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Faron Pharmaceuticals Oy stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Faron Pharmaceuticals Oy (FARN.L) that investors often compare it to?
Faron Pharmaceuticals Oy (FARN.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Viridian Therapeutics and Avacta Group Plc.
What is the forecast for Faron Pharmaceuticals Oy's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Faron Pharmaceuticals Oy's stock price to be around £207.2 in 2026. Starting from the current price of £210, this represents a 1.4% change in price, indicating a neutral outlook for the stock.
How to buy Faron Pharmaceuticals Oy (FARN.L) Stock?
Faron Pharmaceuticals Oy stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Faron Pharmaceuticals Oy shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.